- Home
- PKE vs HUMA Comparison
PKE vs HUMA Comparison
Compare PKE & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKE
- HUMA
- Stock Information
- Founded
- PKE 1954
- HUMA 2004
- Country
- PKE United States
- HUMA United States
- Employees
- PKE N/A
- HUMA N/A
- Industry
- PKE Military/Government/Technical
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- PKE Industrials
- HUMA Health Care
- Exchange
- PKE Nasdaq
- HUMA Nasdaq
- Market Cap
- PKE 352.8M
- HUMA 250.2M
- IPO Year
- PKE N/A
- HUMA N/A
- Fundamental
- Price
- PKE $18.66
- HUMA $1.51
- Analyst Decision
- PKE
- HUMA Strong Buy
- Analyst Count
- PKE 0
- HUMA 8
- Target Price
- PKE N/A
- HUMA $10.88
- AVG Volume (30 Days)
- PKE 111.5K
- HUMA 5.9M
- Earning Date
- PKE 10-14-2025
- HUMA 08-11-2025
- Dividend Yield
- PKE 2.67%
- HUMA N/A
- EPS Growth
- PKE 4.18
- HUMA N/A
- EPS
- PKE 0.34
- HUMA N/A
- Revenue
- PKE $63,456,000.00
- HUMA $818,000.00
- Revenue This Year
- PKE N/A
- HUMA N/A
- Revenue Next Year
- PKE N/A
- HUMA $949.92
- P/E Ratio
- PKE $55.71
- HUMA N/A
- Revenue Growth
- PKE 16.60
- HUMA N/A
- 52 Week Low
- PKE $11.97
- HUMA $1.15
- 52 Week High
- PKE $20.73
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- PKE 62.12
- HUMA 36.87
- Support Level
- PKE $18.81
- HUMA $1.43
- Resistance Level
- PKE $19.54
- HUMA $1.67
- Average True Range (ATR)
- PKE 0.59
- HUMA 0.15
- MACD
- PKE 0.02
- HUMA -0.01
- Stochastic Oscillator
- PKE 77.04
- HUMA 23.32
About PKE Park Aerospace Corp.
Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.